BIO and PhRMA file petition supporting Illumina

07-03-2017

BIO and PhRMA file petition supporting Illumina

JamesBrey / iStockphoto.com

Two biotech associations have filed a petition asking the US Court of Appeals for the Federal Circuit to clarify rules on whether arguments can be brought at a district court if they have been brought at the US Patent and Trademark Office.


BIO, PhRMA, petition, Federal Circuit, Illumina, Ariosa, IPR, patent, patent infringement, inter partes review

LSIPR